Feature|Articles|November 15, 2024
- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
Pharmaceutical Executive: November 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
AI’s Attention Spanover 1 year ago
Noam Solomon: Bringing the Human Story to AIover 1 year ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineover 1 year ago
The Leap Forward: Practical Gains for Pharma AI Useover 1 year ago
Powering Pipelines Forward: Approach Science Differentlyover 1 year ago
Navigating the Current Landscape for Pharma Leadersover 1 year ago
Passage to Asia: Early Access for Innovative Therapiesover 1 year ago
Digital Protection: Q&A with Jeffrey BernsteinNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5